NewsBenzingaTranscript: Iovance Biotherapeutics Q2 2026 Earnings Conference Call Transcript: Iovance Biotherapeutics Q2 2026 Earnings Conference Call Benzinga 2026.10.06 08:00 (GMT+0) Open on Benzinga Other news Soneium Plans to Support On-Chain IP Asset and License Registration Standard ERC-8432 Here's What to Expect From Cadence Design's Next Earnings Report Delta Airlines Earnings Trade: A High Probability Options Setup Earnings Preview: What To Expect From Hasbro’s Report BIT Appoints Former OSL Group CMO Jack Derong as New Chief Marketing Officer Why On Semiconductor Is Betting Big on AI Power and What Its $5.7 Billion Bet Means for ON Stock
